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Materials and Methods 
Cell lines and culture 
Mouse embryo fibroblasts obtained from M. Yamamoto and S. Akira were grown in 
DMEM with 10% fetal calf serum.  100% confluent cells were treated for 48 hours with 
0.5% serum containing medium and then stimulated with 0.5 µg/mL lipopolysaccharide 
(Sigma-Aldrich, St. Louis, MO) or 10 ng/mL murine TNFα (Roche, Palo Alto, CA ).  
Where indicated, cells were pre-treated for 60 minutes with 25µg/mL cycloheximide 
(Sigma-Aldrich).  Neutralizing antibodies and soluble receptors were obtained from R&D 
Systems, Inc. (Minneapolis, MN), and media concentrations were determined from the 
given ED50 range. 
 
Electrophoretic Mobility Shift Assay (EMSA) 
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EMSA was performed as described elsewhere (S1).  Samples were normalized by 
Bradford assay.  Every experiment was performed at least twice, most three times with 
high-reproducibility.  
 
ELISA 
After the cells were stimulated, 50 µL of medium was taken and analyzed according to 
the manufacturer’s instructions (www.biosource.com).   
 
RNA isolation and gene expression determination 
Total RNA was isolated using a Qiagen RNEasy kit with on-column DNAse digestion 
(city, state), according to manufacturer’s instructions (www.qiagen.com), and hybridized 
to Affymetrix Mouse Genome 430 2.0 Gene Chips, according to specified protocols 
(www.affymetrix.com).  Rosetta Resolver (Rosetta Biosoftware, Seattle, WA) was used 
to normalize and analyze the chip data.   
 
cDNA synthesis was performed according to manufacturer’s instructions 
(www.appliedbiosystems.com).  Q-PCR was performed using Sybr Green PCR Master 
Mix (Applied Biosystems, Foster City, CA) and an Applied Biosystems Real-Time PCR 
machine.  Samples were performed in triplicate and GAPDH or β-actin transcript was 
used to normalize between samples.  Every experiment was performed at least twice, 
many three times with high reproducibility.  Primer sequences are available upon request.   
 
 2
siRNA  The siRNA vectors and production were produced as described elsewhere 
(S2,S3).  
 
IKK Assay 
Anti-IKKγ immunoprecipitates (Santa Cruz Biotechnologies SC-8256) from WT, Trif-, 
and MyD88-deficient extracts stimulated with LPS for the indicated times were assayed 
for 30 minutes by a standard immune complex kinase assay.  GST-IκBα (1-62) was used 
as a substrate.  To ensure equal loading, Western analysis was performed using an anti-
IKKα antibody (Imgenex IMG-136). 
 
Computational Methods 
We described a model used to describe the feedback control of NF-κB by IκBα 
previously (1).  This model does not explicitly include upstream pathways, but was made 
to describe the response of immortalized mouse embryo fibroblasts to TNFα.  This model 
was modified and expanded to enable simulation of the TLR-4 pathways to NF-κB 
activation, as described below.  We used Berkeley Madonna software (Berkeley, CA) to 
perform all of the calculations described here. 
 
Modifications 
The parameters of oscillation observed in our specific cell type differed from those 
observed in our earlier study, and therefore we re-fit some of the parameters based on our 
own EMSA measurements of wild-type MEFs stimulated with TNFα as described above.  
The resulting parameter changes are shown in Table S1. 
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 For all of the parameters, the changes are relatively minor and mostly serve to decrease 
the oscillatory period.  In three cases (k1, tr1, tr2), no measurement has been made and 
the previous model also determined these parameters by a fit.  In the case of tr3, one 
study determined a spontaneous half-life of ~30 minutes for IκB RNA transcripts.  Our 
degradation rate roughly corresponds to a half-life of 15 minutes, and the model was 
comparatively sensitive to this parameter. 
 
Expansion 
To simulate the interactions between the MyD88-dependent and -independent pathways, 
we represented each pathway as a first-order process with parameters as shown in Figure 
2C.  The parameters were fit using Berkeley Madonna’s curve fitting function.  LPS 
stimulation was represented as a step input of 0.09.  Model files are available upon 
request. 
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Figure S1.  IRF-3 knockdown controls.  (A) EMSA was used to determine activation of 
NF-κB in MyD88-deficient MEFs stimulated for 90 minutes with LPS or TNFα, where 
siRNA was inserted in a lentiviral vector to knockdown the expression of IRF-3 or LacZ 
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(2, 3).  The reduction in IRF-3 expression was approximately 4-fold, as confirmed by 
Western blot. 
Tables  
Table S1.  Parameter changes made to the Hoffmann/Levchenko model (S1).  “Old” 
represents the H/L parameter, while “New” represents the value used in this study. 
Symbol [units] Old New Description 
k1 [-] 5.4 3.0 Nuclear NF-κB transport rate constant 
tr1 [-] 0.2448 0.40 IκB translation rate constant 
tr2 [-] 0.99 0.94 Enhancement of NF-κB on translation of IκBα 
tr3 [1/min] 0.0168 0.08 Degradation rate of IκB transcripts 
 
Table S2.  Significant gene expression after 45 minutes of 
LPS stimulation as detected by Affymetrix microarray.    
Gene Name Intensity Fold Change P-value 
Scyb2/MIP-2 22.3 7.10E-42 
TNFa 13.0 2.20E-20 
Tnfsf9/4-1BB 7.1 8.30E-20 
Scya4/MIP-1ß 6.5 6.30E-08 
CD-83 6.4 1.00E-13 
Scya3/MIP-1a 4.2 8.20E-15 
Scyb10/IP-10 3.4 3.20E-04 
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